education_AdobeStock_©-Robert-Kneschke_251314673_2000px_191205

Project

PATH2XNAT

PATH2XNAT- XNAT and GALAXY based platform for accelerated research on the pathogenesis of infectious diseases

 

 

Duration of the project: November 2023 - July 2025

 

Many SARS-CoV-2 patients in intensive care were presented with hypercoagulation causing fatal thrombosis. Analysis of SARS-CoV-2 infected lungs revealed post-infection immunological responses. Further research on the interactions between SARS-CoV-2 and its receptors has led to novel prevention and treatment strategies. To accelerate such research on the pathogenesis in other infectious diseases, a streamlined data management and analysis platform is needed.

The aim of this project is to develop a data management and analysis platform, called PATH2XNAT https://bigr.nl/project/path2xnat/, built on top of existing platforms XNAT and Galaxy (Galaxy is an open-source bioinformatics workflow platform, supported by ELIXIR-NL, which has been used for automated SARS-CoV-2 genome surveillance (https://www.infectious-diseases-toolkit.org/showcase), to accelerate research on the pathogenesis of infectious diseases.

 

 

 

Latest News

SBHD 2024

Our colleagues at Vanderbilt University organise the 16th INTERNATIONAL CONFERENCE ON SYSTEMS BIOLOGY OF HUMAN DISEASE – SBHD 2024 this year from June 10-12. Don’t miss the opportunity to participate

Top 100 Köpfe der Wissenschaft 2023

Am 11.10.2023 wurde Prof. Roland Eils im Tagesspiegel als einer der 100 wichtigsten Köpfe der Hauptstadt-Wissenschaft gewürdigt. So schreibt der Tagesspiegel: "Um Big Data dreht sich alles in der

Young BIH scientists attend 72nd Lindau Nobel Laureate Meeting

The Lindau Nobel Laureate Meetings are annual conferences where some of the brightest minds in science converge to exchange knowledge, foster collaboration, and inspire the next generation of

Roland Eils wird als Highly Cited Researcher international gelistet.

Roland Eils gehört zu den weltweit am häufigsten zitierten Forschenden des Jahres 2022, wie aus der Liste der „Highly Cited Researchers“ hervorgeht, die das Unternehmen Clarivate heute veröffentlicht